Vimarsana
Biggest News Aggregation in the World

Page 48 - Nt Ears News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nt Ears. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nt Ears Today - Breaking & Trending Today

Neurotoxin to Avert Postoperative AF: Patient Selection Clues in NOVA - Vimarsana News

Neurotoxin to Avert Postoperative AF: Patient Selection Clues in NOVA

The procedure's success seemed to depend on dosage, patient age, and type of cardiac surgery in this small phase-2 study with a sham-control group.

Add Tezepelumab to SCIT to Improve Cat Allergy Symptoms? - Vimarsana News

Add Tezepelumab to SCIT to Improve Cat Allergy Symptoms?

Adding tezepelumab to cat allergy shots may provide better, longer-lasting symptom relief than allergy shots alone for patients with allergic rhinitis due to cat allergens, researchers report.

Study Affirms Shorter Regimens for Drug-Resistant Tuberculosis - Vimarsana News

Study Affirms Shorter Regimens for Drug-Resistant Tuberculosis

Two short-course bedaquiline-containing regimens are promising treatment options for multidrug-resistant tuberculosis.

Half of World's Young People at Risk for Hearing Loss: Study - Vimarsana News

Half of World's Young People at Risk for Hearing Loss: Study

The study found that as many as 1 in 4 people ages 12-34 are exposed to dangerous noise levels via 'personal listening devices.'

Peanut-Allergic Toddlers Also Benefit From Oral Immunotherapy With Palforzia - Vimarsana News

Peanut-Allergic Toddlers Also Benefit From Oral Immunotherapy With Palforzia

New research findings show that an FDA-approved oral immunotherapy for older children and adolescents safely increased peanut protein tolerance in peanut-allergic children aged 1-3 years.